Induction immunosuppression with interleukin-2 receptor antibodies (basiliximab and daclizumab) in renal transplant recipients

Autor: Nair, M.P, Nampoory, M.R.N, Johny, K.V *, Costandi, J.N, Abdulhalim, M, El-Reshaid, W, Al-Muzairai, I, Ninan, V.T, Samhan, M, Al-Mousawi, M
Zdroj: In Transplantation Proceedings 2001 33(5):2767-2769
Databáze: ScienceDirect